$25.75
0.66% today
Nasdaq, Sep 23, 04:20 pm CET
ISIN
US45166A1025
Symbol
IDYA

IDEAYA Biosciences Inc Target price 2025 - Analyst rating & recommendation

IDEAYA Biosciences Inc Classifications & Recommendation:

Buy
86%
Hold
14%

IDEAYA Biosciences Inc Price Target

Target Price $45.90
Price $25.92
Potential
Number of Estimates 18
18 Analysts have issued a price target IDEAYA Biosciences Inc 2026 . The average IDEAYA Biosciences Inc target price is $45.90. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 22 analysts: 19 Analysts recommend IDEAYA Biosciences Inc to buy, 3 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the IDEAYA Biosciences Inc stock has an average upside potential 2026 of . Most analysts recommend the IDEAYA Biosciences Inc stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 7.00 11.44
70.07% 63.41%
EBITDA Margin -4,637.00% -2,798.43%
721.97% 39.65%
Net Margin -3,921.14% -2,646.41%
711.93% 32.51%

20 Analysts have issued a sales forecast IDEAYA Biosciences Inc 2025 . The average IDEAYA Biosciences Inc sales estimate is

$11.4m
Unlock
. This is
63.41% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$29.6m 323.00%
Unlock
, the lowest is
$0.0 100.00%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $7.0m 70.07%
2025
$11.4m 63.41%
Unlock
2026
$46.4m 305.49%
Unlock
2027
$117m 151.51%
Unlock
2028
$272m 133.34%
Unlock
2029
$525m 93.02%
Unlock
2030
$894m 70.18%
Unlock
2031
$1.4b 57.68%
Unlock
2032
$1.8b 28.37%
Unlock

6 Analysts have issued an IDEAYA Biosciences Inc EBITDA forecast 2025. The average IDEAYA Biosciences Inc EBITDA estimate is

$-320m
Unlock
. This is
16.19% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-304m 20.35%
Unlock
, the lowest is
$-327m 14.31%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $-325m 145.99%
2025
$-320m 1.38%
Unlock
2026
$-332m 3.67%
Unlock
2027
$-252m 23.94%
Unlock

EBITDA Margin

2024 -4,637.00% 721.97%
2025
-2,798.43% 39.65%
Unlock
2026
-715.45% 74.43%
Unlock
2027
-216.37% 69.76%
Unlock

17 IDEAYA Biosciences Inc Analysts have issued a net profit forecast 2025. The average IDEAYA Biosciences Inc net profit estimate is

$-303m
Unlock
. This is
8.63% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-276m 16.67%
Unlock
, the lowest is
$-311m 6.16%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-274m 142.99%
2025
$-303m 10.29%
Unlock
2026
$-294m 2.84%
Unlock
2027
$-267m 9.28%
Unlock
2028
$-170m 36.30%
Unlock
2029
$-47.4m 72.12%
Unlock
2030
$147m 410.76%
Unlock
2031
$433m 194.35%
Unlock
2032
$661m 52.60%
Unlock

Net Margin

2024 -3,921.14% 711.93%
2025
-2,646.41% 32.51%
Unlock
2026
-634.11% 76.04%
Unlock
2027
-228.73% 63.93%
Unlock
2028
-62.44% 72.70%
Unlock
2029
-9.02% 85.55%
Unlock
2030
16.47% 282.59%
Unlock
2031
30.74% 86.64%
Unlock
2032
36.54% 18.87%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ -3.36 -3.45
71.43% 2.68%
P/E negative
EV/Sales 140.05

17 Analysts have issued a IDEAYA Biosciences Inc forecast for earnings per share. The average IDEAYA Biosciences Inc EPS is

$-3.45
Unlock
. This is
8.24% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$-3.15 16.22%
Unlock
, the lowest is
$-3.55 5.59%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-3.36 71.43%
2025
$-3.45 2.68%
Unlock
2026
$-3.36 2.61%
Unlock
2027
$-3.04 9.52%
Unlock
2028
$-1.94 36.18%
Unlock
2029
$-0.54 72.16%
Unlock
2030
$1.68 411.11%
Unlock
2031
$4.95 194.64%
Unlock
2032
$7.55 52.53%
Unlock

P/E ratio

Current -6.89 61.20%
2025
-7.50 8.80%
Unlock
2026
-7.72 2.93%
Unlock
2027
-8.51 10.23%
Unlock
2028
-13.36 56.99%
Unlock
2029
-47.95 258.91%
Unlock
2030
15.43 132.18%
Unlock
2031
5.24 66.04%
Unlock
2032
3.43 34.54%
Unlock

Based on analysts' sales estimates for 2025, the IDEAYA Biosciences Inc stock is valued at an EV/Sales of

140.05
Unlock
and an P/S ratio of
198.59
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 228.85 21.37%
2025
140.05 38.80%
Unlock
2026
34.54 75.34%
Unlock
2027
13.73 60.24%
Unlock
2028
5.88 57.14%
Unlock
2029
3.05 48.19%
Unlock
2030
1.79 41.24%
Unlock
2031
1.14 36.58%
Unlock
2032
0.89 22.10%
Unlock

P/S ratio

Current 324.53 31.27%
2025
198.59 38.81%
Unlock
2026
48.98 75.34%
Unlock
2027
19.47 60.24%
Unlock
2028
8.35 57.14%
Unlock
2029
4.32 48.19%
Unlock
2030
2.54 41.24%
Unlock
2031
1.61 36.58%
Unlock
2032
1.26 22.10%
Unlock

Current IDEAYA Biosciences Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Guggenheim
Locked
Locked
Locked Sep 18 2025
Mizuho
Locked
Locked
Locked Sep 12 2025
RBC Capital
Locked
Locked
Locked Sep 09 2025
Stephens & Co.
Locked
Locked
Locked Sep 09 2025
Cantor Fitzgerald
Locked
Locked
Locked Sep 09 2025
JMP Securities
Locked
Locked
Locked Sep 08 2025
JMP Securities
Locked
Locked
Locked Sep 04 2025
Analyst Rating Date
Locked
Guggenheim:
Locked
Locked
Sep 18 2025
Locked
Mizuho:
Locked
Locked
Sep 12 2025
Locked
RBC Capital:
Locked
Locked
Sep 09 2025
Locked
Stephens & Co.:
Locked
Locked
Sep 09 2025
Locked
Cantor Fitzgerald:
Locked
Locked
Sep 09 2025
Locked
JMP Securities:
Locked
Locked
Sep 08 2025
Locked
JMP Securities:
Locked
Locked
Sep 04 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today